epirubicin has been researched along with Amaurosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amdur, RJ; Hinerman, RW; Mendenhall, WM; Monroe, AT; Morris, CG | 1 |
| Folga, A; Fryze, W; Jassem, E; Mincewicz, H; Olszewska, A; Słomiński, JM | 1 |
2 other study(ies) available for epirubicin and Amaurosis
| Article | Year |
|---|---|
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blindness; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cytarabine; Epirubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Irradiation; Lymphatic Metastasis; Male; Middle Aged; Nasal Cavity; Necrosis; Neoplasm Recurrence, Local; Nose Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Salvage Therapy; Spinal Cord Neoplasms; Survival Analysis | 2003 |
[A case of binocular blindness in small cell lung cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Carcinoma, Small Cell; Cyclophosphamide; Epirubicin; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Male; Paraneoplastic Syndromes | 1998 |